Major Depressive Disorder
Pipeline by Development Stage
Drug Modality Breakdown
On Market (17)
Approved therapies currently available
Competitive Landscape
91 companies ranked by most advanced pipeline stage
+61 more companies
Trial Timeline
Clinical trial activity over time
Showing 15 of 50 trials with date data
Clinical Trials (50)
Total enrollment: 19,416 patients across 50 trials
To Evaluate the Long-term Efficacy and Safety of Toludevenlafaxine Hydrochloride Sustained-release Tablets
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
Brexpiprazole as Adjunctive Therapy in Adults With Major Depressive Disorder
Leveraging EEG for Antidepressant Prediction With Sertraline and Escitalopram
Leveraging EEG for Antidepressant Prediction With Duloxetine and Bupropion
Comparison of Vortioxetine and Desvenlafaxine in Adult Patients Suffering From Depression
Vortioxetine in Patients With Depression and Early Dementia
Open-label, Flexible-dose Study of Vortioxetine in Patients With Depression in India
Study With Vortioxetine on Emotional Functioning in Patients With Depression
Vortioxetine in the Elderly vs. Selective Serotonin Reuptake Inhibitors (SSRIs): a Pragmatic Assessment
Brainsway DTMS for Treatment of MDD Using iTBS
Trial of Levomilnacipran in Geriatric Depression
Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder (MDD)
Assessment in Work Productivity and the Relationship With Cognitive Symptoms in Patients With MDD Taking Vortioxetine
Desvenlafaxine in Opioid-Dependent Patients
Vilazodone for Treatment of Geriatric Depression
Lexapro®'s Efficacy After Dose Escalation in Remission Study
Iloperidone Augmentation of SSRIs for Patients With Major Depressive Disorder With Residual Anger and Irritability
Aripiprazole (Abilify®) as an Adjunctive Treatment for Inadequate Response in Major Depressive Disorder
Effect of Antidepressants on White Matter Structure
Aripiprazole for the Augmentation of Antidepressant Therapy
Biomarkers of Antidepressant Treatment in Adolescents With Major Depression (The Adolescents MDD Study)
A Study in Depression and Associated Painful Physical Symptoms
A Study of the Neurobiology of Depression
A Study of Duloxetine in Major Depressive Disorder (MDD) and Associated Painful Symptoms
Biomarkers for Outcomes In Late-life Depression (BOLD)
A Study of Patients With Major Depressive Disorder and Residual Apathy
Duloxetine for Major Depression in Peri-/Postmenopausal Women
Study Evaluating Effexor XR in Chinese Subjects With Major Depressive Disorder
Neuroimaging Study of Bupropion Treatment in Patients With Major Depressive Disorder
Early Versus Delayed Switch in Medication in Patients With Major Depressive Disorder
Quantitative Electroencephalogram (QEEG) Predictors of Response to Psychotherapy Versus Antidepressant Treatment in Depression
Brain Mechanisms and Targeting Insomnia in Major Depression
A Study Comparing Duloxetine and Placebo in Assessing Energy and Vitality in Major Depressive Disorder (MDD) Patients
Duloxetine Treatment of Major Depression and Chronic Low Back Pain For Older Adults
Study Comparing the Efficacy of Venlafaxine XR Vs. SSRIs and Conventional Antidepressants in Depressed Patients
Study on the Tolerability of Duloxetine in Depressed Patients With Parkinson's Disease
Acamprosate Added to Escitalopram and Behavioral Treatment for Comorbid Depression and Alcoholism
Escitalopram and Sleep Architecture in Patients With Major Depressive Disorder
A Study Evaluating Duloxetine in Patients Hospitalized for Severe Depression
Duloxetine for Perimenopausal Depression
A Study Comparing the Efficacy and Safety of Duloxetine and Placebo for the Treatment of Depression in Elderly Patients
Functional Change and Efficacy of Duloxetine in Patients With Co-Morbid Depression & Soft Tissue Discomfort Syndrome
Efficacy and Tolerability of Escitalopram and Duloxetine in Outpatients With Major Depressive Disorder
A Neuroimaging Investigation of Brain Activity in Major Depressive Disorder and Bipolar Disorder
Switching to Duloxetine From Other Antidepressants
Lilly's Emotional and Physical Symptoms of Depression Study (LEAPS)
Treatment of Nicotine Dependence and Acute Depression
Quantitative EEG (QEEG) as a Predictor of Treatment Outcome in Depression
Electroencephalography (EEG) Biomarkers of Response in Depression
Related Jobs
Specialty Account Manager, Auvelity (Riverside, CA)
Director/Senior Director, Commercial Counsel
Specialty Account Manager, Long Term Care (Jacksonville, FL)
Specialty Account Manager, Long Term Care (Atlanta, GA)
Specialty Account Manager, Long Term Care (Hartford, CT)
Specialty Account Manager, Auvelity (Bloomington, IN)
Phase Legend
Key Insights
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.